The improved sensitive detection of C-reactive protein based on the chemiluminescence immunoassay by employing monodispersed PAA-Au/Fe3O4 nanoparticles and zwitterionic glycerophosphoryl choline

2017 ◽  
Vol 5 (21) ◽  
pp. 3919-3926 ◽  
Author(s):  
Yan Xing ◽  
Qin Gao ◽  
Yanmin Zhang ◽  
Le Ma ◽  
Kang Yong Loh ◽  
...  

Monodispersed PAA-Au/Fe3O4 NPs were engineered for highly sensitive CRP assay with zwitterionic glycerophosphoryl choline as the co-blocking agent.

2014 ◽  
Vol 456 ◽  
pp. 32-37 ◽  
Author(s):  
Sandeep Kumar Vashist ◽  
Gregor Czilwik ◽  
Thomas van Oordt ◽  
Felix von Stetten ◽  
Roland Zengerle ◽  
...  

2015 ◽  
Vol 17 (15) ◽  
pp. 9951-9958 ◽  
Author(s):  
Yuri Kamon ◽  
Yukiya Kitayama ◽  
Akiko N. Itakura ◽  
Kyoko Fukazawa ◽  
Kazuhiko Ishihara ◽  
...  

We studied the effects of layer thickness and grafting density of poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) thin layers as specific ligands for the highly sensitive binding of C-reactive protein (CRP).


2017 ◽  
Vol 9 (6) ◽  
pp. 994-1003 ◽  
Author(s):  
Robert Nooney ◽  
Valerie Rebello ◽  
Gemma Keegan ◽  
Claire L. O'Connell ◽  
Daragh Byrne ◽  
...  

A novel dissolution approach was used to achieve enhanced sensitivity in a nanoparticle (NP) immunoassay for the detection of a cardiovascular disease marker, C-reactive protein (CRP).


2006 ◽  
Vol 153 (3) ◽  
pp. 54 ◽  
Author(s):  
K.-K. Sin ◽  
C.P.-Y. Chan ◽  
W.-M. Leung ◽  
M. Seydack ◽  
R. Renneberg

2016 ◽  
Vol 52 (20) ◽  
pp. 3883-3886 ◽  
Author(s):  
Ryo Matsuura ◽  
Keiko Tawa ◽  
Yukiya Kitayama ◽  
Toshifumi Takeuchi

A synthetic polymer ligand-grafted plasmonic chip was fabricated and demonstrated a highly sensitive detection of C-reactive protein (CRP) by grating-coupled surface plasmon field-enhanced fluorescence.


RSC Advances ◽  
2014 ◽  
Vol 4 (55) ◽  
pp. 29022-29031 ◽  
Author(s):  
Yi Zhang ◽  
Denise E. Charles ◽  
Deirdre M. Ledwith ◽  
Damian Aherne ◽  
Stephen Cunningham ◽  
...  

Rapid, wash-free highly sensitive detection of C-reactive protein is reported using nanoplate biosensor sols.


2014 ◽  
Author(s):  
Sandeep Kumar Vashist ◽  
Sandeep Kumar Vashist ◽  
Gregor Czilwik ◽  
Thomas van Oordt ◽  
Felix von Stetten ◽  
...  

2021 ◽  
Vol 102 (4) ◽  
pp. 510-517
Author(s):  
E V Khazova ◽  
O V Bulashova

The discussion continues about the role of systemic inflammation in the pathogenesis of cardiovascular diseases of ischemic etiology. This article reviews the information on the role of C-reactive protein in patients with atherosclerosis and heart failure in risk stratification for adverse cardiovascular events, including assessment of factors affecting the basal level of highly sensitive C-reactive protein. Research data (MRFIT, MONICA) have demonstrated a relationship between an increased level of C-reactive protein and the development of coronary heart disease. An increase in the serum level of highly sensitive C-reactive protein is observed in arterial hypertension, dyslipidemia, type 2 diabetes mellitus and insulin resistance, which indicates the involvement of systemic inflammation in these disorders. Currently, the assessment of highly sensitive C-reactive protein is used to determine the risk of developing myocardial infarction and stroke. It has been proven that heart failure patients have a high level of highly sensitive C-reactive protein compared with patients without heart failure. The level of C-reactive protein is referred to as modifiable risk factors for cardiovascular diseases of ischemic origin, since lifestyle changes or taking drugs such as statins, non-steroidal anti-inflammatory drugs, glucocorticoids, etc. reduce the level of highly sensitive C-reactive protein. In patients with heart failure with different left ventricular ejection fraction values, it was found that the regression of the inflammatory response is accompanied by an improvement in prognosis, which confirms the hypothesis of inflammation as a response to stress, which has negative consequences for the cardiovascular system.


2009 ◽  
Vol 28 (12) ◽  
pp. 739-745 ◽  
Author(s):  
Davood Attaran ◽  
Shahrzad M Lari ◽  
Mohammad Khajehdaluee ◽  
Hossein Ayatollahi ◽  
Mohammad Towhidi ◽  
...  

Background: Sulfur mustard (SM) is a chemical warfare agent that can cause serious pulmonary complications. This study was designed to determine serum highly sensitive C-reactive protein (hs-CRP) and evaluate its correlation with lung function parameters in patients with chronic obstructive pulmonary disease (COPD) due to SM poisoning. Methods: Fifty consecutive SM patients with stable COPD and a mean age 46.3 ± 9.18 years were enrolled in this cross sectional study. Thirty healthy men were selected as controls. Lung function parameters were evaluated. Serum hs-CRP by immunoturbidometry assay was measured in both the patients and controls. Results: In the case group, the mean forced expiratory volume in one second (FEV1) was 2.14 ± 0.76 L (58.98% ± 17.51% predicted). The mean serum hs-CRP was 9.4 ± 6.78 SD and 3.9 ± 1.92 SD mg/L in the cases and controls, respectively, with significant statistical differences (p < .001). There was negative correlation between the serum hs-CRP and FEV1 levels (p = .01). The serum hs-CRP levels were also correlated with Global Initiative for Chronic Obstructive Lung disease (GOLD) stages (r = .45, p < .001). Conclusions: Our findings suggest that the serum hs-CRP level is increased in SM patients with COPD and may have a direct correlation with disease severity. It may then be used as a marker for the severity of COPD in patients with SM poisoning.


Sign in / Sign up

Export Citation Format

Share Document